Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pandemic influenza A virus vaccines - CSL/NIAID

Drug Profile

Pandemic influenza A virus vaccines - CSL/NIAID

Alternative Names: Focetria (Mock-up); Foclivia; Influenza A virus H5N1/H9N2 subtypes vaccine - CSL/NIAID

Latest Information Update: 29 Apr 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator National Institute of Allergy and Infectious Diseases; Novartis
  • Developer CSL
  • Class Influenza A vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Registered Influenza A virus H5N1 subtype; Influenza A virus infections

Most Recent Events

  • 23 Mar 2021 Seqirus entered manufacturing and supply agreement with Government of Canada for influenza vaccine
  • 23 Mar 2021 Registered for Influenza A virus H5N1 subtype (Prevention) in Canada (Parenteral)
  • 13 Jan 2010 Interim immunogenicity data from a clinical study in patients with end-stage renal disease released by SciCLone and Sigma-Tau
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top